Report Detail
Global Live Cell Encapsulation Supply, Demand and Key Producers, 2026-2032
- RnM4667412 |
- 22 January, 2026 |
- Global |
- 102 Pages |
- GIR |
- Pharma & Healthcare
The global Live Cell Encapsulation market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032).
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.
This report studies the global Live Cell Encapsulation demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Cell Encapsulation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Cell Encapsulation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Live Cell Encapsulation total market, 2021-2032, (USD Million)
Global Live Cell Encapsulation total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Live Cell Encapsulation total market, key domestic companies, and share, (USD Million)
Global Live Cell Encapsulation revenue by player, revenue and market share 2021-2026, (USD Million)
Global Live Cell Encapsulation total market by Type, CAGR, 2021-2032, (USD Million)
Global Live Cell Encapsulation total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Live Cell Encapsulation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Live Cell Encapsulation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Live Cell Encapsulation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Live Cell Encapsulation Market, Segmentation by Type:
Alginate
Chitosan
Cellulose
Others
Global Live Cell Encapsulation Market, Segmentation by Application:
Diabetes
Cancer
Epilepsy
Parkinson
Others
Companies Profiled:
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Key Questions Answered
1. How big is the global Live Cell Encapsulation market?
2. What is the demand of the global Live Cell Encapsulation market?
3. What is the year over year growth of the global Live Cell Encapsulation market?
4. What is the total value of the global Live Cell Encapsulation market?
5. Who are the Major Players in the global Live Cell Encapsulation market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Live Cell Encapsulation Introduction
- 1.2 World Live Cell Encapsulation Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World Live Cell Encapsulation Total Market by Region (by Headquarter Location)
- 1.3.1 World Live Cell Encapsulation Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.3 China Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.4 Europe Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.5 Japan Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.6 South Korea Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.7 ASEAN Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.3.8 India Based Company Live Cell Encapsulation Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Live Cell Encapsulation Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World Live Cell Encapsulation Consumption Value (2021-2032)
- 2.2 World Live Cell Encapsulation Consumption Value by Region
- 2.2.1 World Live Cell Encapsulation Consumption Value by Region (2021-2026)
- 2.2.2 World Live Cell Encapsulation Consumption Value Forecast by Region (2027-2032)
- 2.3 United States Live Cell Encapsulation Consumption Value (2021-2032)
- 2.4 China Live Cell Encapsulation Consumption Value (2021-2032)
- 2.5 Europe Live Cell Encapsulation Consumption Value (2021-2032)
- 2.6 Japan Live Cell Encapsulation Consumption Value (2021-2032)
- 2.7 South Korea Live Cell Encapsulation Consumption Value (2021-2032)
- 2.8 ASEAN Live Cell Encapsulation Consumption Value (2021-2032)
- 2.9 India Live Cell Encapsulation Consumption Value (2021-2032)
3 World Live Cell Encapsulation Companies Competitive Analysis
- 3.1 World Live Cell Encapsulation Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Live Cell Encapsulation Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Live Cell Encapsulation in 2025
- 3.2.3 Global Concentration Ratios (CR8) for Live Cell Encapsulation in 2025
- 3.3 Live Cell Encapsulation Company Evaluation Quadrant
- 3.4 Live Cell Encapsulation Market: Overall Company Footprint Analysis
- 3.4.1 Live Cell Encapsulation Market: Region Footprint
- 3.4.2 Live Cell Encapsulation Market: Company Product Type Footprint
- 3.4.3 Live Cell Encapsulation Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: Live Cell Encapsulation Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Live Cell Encapsulation Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: Live Cell Encapsulation Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: Live Cell Encapsulation Consumption Value Comparison
- 4.2.1 United States VS China: Live Cell Encapsulation Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Live Cell Encapsulation Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based Live Cell Encapsulation Companies and Market Share, 2021-2026
- 4.3.1 United States Based Live Cell Encapsulation Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Live Cell Encapsulation Revenue, (2021-2026)
- 4.4 China Based Companies Live Cell Encapsulation Revenue and Market Share, 2021-2026
- 4.4.1 China Based Live Cell Encapsulation Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Live Cell Encapsulation Revenue, (2021-2026)
- 4.5 Rest of World Based Live Cell Encapsulation Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based Live Cell Encapsulation Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies Live Cell Encapsulation Revenue (2021-2026)
5 Market Analysis by Type
- 5.1 World Live Cell Encapsulation Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Alginate
- 5.2.2 Chitosan
- 5.2.3 Cellulose
- 5.2.4 Others
- 5.3 Market Segment by Type
- 5.3.1 World Live Cell Encapsulation Market Size by Type (2021-2026)
- 5.3.2 World Live Cell Encapsulation Market Size by Type (2027-2032)
- 5.3.3 World Live Cell Encapsulation Market Size Market Share by Type (2027-2032)
6 Market Analysis by Application
- 6.1 World Live Cell Encapsulation Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Diabetes
- 6.2.2 Cancer
- 6.2.3 Epilepsy
- 6.2.4 Parkinson
- 6.2.5 Others
- 6.3 Market Segment by Application
- 6.3.1 World Live Cell Encapsulation Market Size by Application (2021-2026)
- 6.3.2 World Live Cell Encapsulation Market Size by Application (2027-2032)
- 6.3.3 World Live Cell Encapsulation Market Size Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Viacyte, Inc.
- 7.1.1 Viacyte, Inc. Details
- 7.1.2 Viacyte, Inc. Major Business
- 7.1.3 Viacyte, Inc. Live Cell Encapsulation Product and Services
- 7.1.4 Viacyte, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Viacyte, Inc. Recent Developments/Updates
- 7.1.6 Viacyte, Inc. Competitive Strengths & Weaknesses
- 7.2 Living Cell Technologies Ltd.
- 7.2.1 Living Cell Technologies Ltd. Details
- 7.2.2 Living Cell Technologies Ltd. Major Business
- 7.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Product and Services
- 7.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Living Cell Technologies Ltd. Recent Developments/Updates
- 7.2.6 Living Cell Technologies Ltd. Competitive Strengths & Weaknesses
- 7.3 Sigilon Therapeutics, Inc
- 7.3.1 Sigilon Therapeutics, Inc Details
- 7.3.2 Sigilon Therapeutics, Inc Major Business
- 7.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Product and Services
- 7.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 Sigilon Therapeutics, Inc Recent Developments/Updates
- 7.3.6 Sigilon Therapeutics, Inc Competitive Strengths & Weaknesses
- 7.4 Sernova Corporation
- 7.4.1 Sernova Corporation Details
- 7.4.2 Sernova Corporation Major Business
- 7.4.3 Sernova Corporation Live Cell Encapsulation Product and Services
- 7.4.4 Sernova Corporation Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 Sernova Corporation Recent Developments/Updates
- 7.4.6 Sernova Corporation Competitive Strengths & Weaknesses
- 7.5 PharmaCyte Biotech Inc
- 7.5.1 PharmaCyte Biotech Inc Details
- 7.5.2 PharmaCyte Biotech Inc Major Business
- 7.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Product and Services
- 7.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 PharmaCyte Biotech Inc Recent Developments/Updates
- 7.5.6 PharmaCyte Biotech Inc Competitive Strengths & Weaknesses
- 7.6 Gloriana Therapeutics
- 7.6.1 Gloriana Therapeutics Details
- 7.6.2 Gloriana Therapeutics Major Business
- 7.6.3 Gloriana Therapeutics Live Cell Encapsulation Product and Services
- 7.6.4 Gloriana Therapeutics Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 Gloriana Therapeutics Recent Developments/Updates
- 7.6.6 Gloriana Therapeutics Competitive Strengths & Weaknesses
- 7.7 Kadimastem
- 7.7.1 Kadimastem Details
- 7.7.2 Kadimastem Major Business
- 7.7.3 Kadimastem Live Cell Encapsulation Product and Services
- 7.7.4 Kadimastem Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.7.5 Kadimastem Recent Developments/Updates
- 7.7.6 Kadimastem Competitive Strengths & Weaknesses
- 7.8 Beta-O2 Technologies, Inc.
- 7.8.1 Beta-O2 Technologies, Inc. Details
- 7.8.2 Beta-O2 Technologies, Inc. Major Business
- 7.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product and Services
- 7.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.8.5 Beta-O2 Technologies, Inc. Recent Developments/Updates
- 7.8.6 Beta-O2 Technologies, Inc. Competitive Strengths & Weaknesses
- 7.9 Altucell, Inc.
- 7.9.1 Altucell, Inc. Details
- 7.9.2 Altucell, Inc. Major Business
- 7.9.3 Altucell, Inc. Live Cell Encapsulation Product and Services
- 7.9.4 Altucell, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.9.5 Altucell, Inc. Recent Developments/Updates
- 7.9.6 Altucell, Inc. Competitive Strengths & Weaknesses
- 7.10 Diatranz Otsuka Ltd
- 7.10.1 Diatranz Otsuka Ltd Details
- 7.10.2 Diatranz Otsuka Ltd Major Business
- 7.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Product and Services
- 7.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue, Gross Margin and Market Share (2021-2026)
- 7.10.5 Diatranz Otsuka Ltd Recent Developments/Updates
- 7.10.6 Diatranz Otsuka Ltd Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Live Cell Encapsulation Industry Chain
- 8.2 Live Cell Encapsulation Upstream Analysis
- 8.3 Live Cell Encapsulation Midstream Analysis
- 8.4 Live Cell Encapsulation Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Live Cell Encapsulation. Industry analysis & Market Report on Live Cell Encapsulation is a syndicated market report, published as Global Live Cell Encapsulation Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Live Cell Encapsulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
